Medical devices industry deals in Q3 2020 total $98.5bn globally

18 November 2020 (Last Updated November 18th, 2020 03:10)

Medical devices industry deals in Q3 2020 total $98.5bn globally

Total medical devices industry deals for Q3 2020 worth $98.5bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 1039.5% over the previous quarter and a rise of 860% when compared with the last four-quarter average of $10.26bn.

In terms of number of deals, the sector saw a rise of 15.7% over the last four-quarter average with 508 deals against the average of 439 deals.

In value terms, North America led the activity with deals worth $93.96bn.

Medical devices industry deals in Q3 2020: Top deals

The top five medical devices deals accounted for 89.4% of the overall value during Q3 2020.

The combined value of the top five medical devices deals stood at $88.01bn, against the overall value of $98.5bn recorded for the month.

The top five medical devices industry deals of Q3 2020 tracked by GlobalData were:

1) Vilex in Tennessee’s $62bn acquisition of DT MedTech

2) The $16.4bn acquisition of Varian Medical Systems by Siemens Healthineers

3) Illumina’s $8bn acquisition of Grail

4) The $825m private equity deal with NN by ASP Navigate Acquisition

5) Patricia Industries’ acquisition of Advanced Instruments for $780m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.